Benzinga Pro data, Arcadia Biosciences (NASDAQ:RKDA) reported Q2 sales of $1.41 million. Earnings fell to a loss of $7.68 million, resulting in a 44.25% decrease from last quarter.
Arcadia Biosciences Launches Search For New CEO, Current COE Matt Plavan To Step Down Once Successor Named
September 7, 4:17 PM
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that it has launched a national search for a new Chief Executive Officer as
August 31, 7:33 AM
Gainers Regional Health Properties Inc (NYSE: RHE) rose 50.3% to $12.49 in pre-market trading after jumping over 15% on Monday. The company, earlier during the month, reported Q2 results.
August 17, 8:58 AM
TPCO Holding Corp. (NEO: GRAM.U) (OTCQX: GRAMF), which does business as The Parent Company, announced its second-quarter financial results on Monday, revealing net sales of $54.2 million, representing approximately 18.9% growth compared to the adjusted Q1 2021 rev
Arcadia Biosciences Q2 Net Loss $5.261M vs $9.689M In Same Qtr. Last Year, Sales $1.41M Miss $1.71M Estimate
August 16, 4:22 PM
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly sales of $1.41 million which missed the analyst consensus estimate of $1.71 million by 17.84 percent. This is a 400.00 percent increase over sales of $281.00 thousand
August 16, 4:04 AM
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.
June 1, 6:51 AM
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and raises the price target from $6 to $7.